サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1765375

子宮頸部異形成診断の世界市場

Cervical Dysplasia Diagnostics

出版日
ページ情報
英文 196 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.05円
子宮頸部異形成診断の世界市場
出版日: 2025年07月09日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 196 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

子宮頸部異形成診断の世界市場は2030年までに8億9,770万米ドルに達する見込み

2024年に6億3,780万米ドルと推定される子宮頸部異形成診断の世界市場は、2024～2030年の分析期間においてCAGR 5.9%で成長し、2030年には8億9,770万米ドルに達すると予測されます。本レポートで分析したセグメントの1つである診断テストは、CAGR 6.0％を記録し、分析期間終了時には7億9,380万米ドルに達すると予測されます。診断機器セグメントの成長率は、分析期間中CAGR 5.1%と推定されます。

米国市場は1億7,570万米ドルと推定、中国はCAGR5.4％で成長予測

米国の子宮頸部異形成診断市場は、2024年に1億7,570万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに1億3,930万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは5.4%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ5.4％と4.7％と予測されています。欧州では、ドイツがCAGR 4.8%で成長すると予測されています。

世界の子宮頸部異形成診断市場- 主要動向と促進要因まとめ

子宮頸部異形成がヘルスケアで注目される理由とは？

子宮頸部異形成は、主にヒトパピローマウイルス（HPV）が原因で子宮頸部の表面に異常な細胞増殖が起こる前がん状態です。子宮頸部異形成の早期発見は、子宮頸がんへの進行を防ぐ上で極めて重要であり、女性ヘルスケアにおいて診断が不可欠となっています。子宮頸がん予防の意識が高まるにつれて、子宮頸部異形成を特定し管理するための診断の重要性も高まっています。検診プログラムが普及し、ヘルスケアシステムが予防対策を重視するようになったことで、パップスメア、HPV検査、コルポスコピーの利用が著しく増加しています。早期診断と早期介入はより良い転帰につながり、特にヘルスケアへのアクセスが改善しつつある地域では、世界的に子宮頸がんの全体的な負担を軽減することができます。

技術革新は子宮頸部異形成診断にどのような影響を与えているか？

技術の進歩は、子宮頸部異形成診断の展望を再構築しています。液体ベースの細胞診やHPVの分子検査など、最新のスクリーニング技術は診断の精度を高め、異常細胞をより早く正確に発見できるようになりました。デジタルコルポスコピー、AIを駆使した診断ツール、病理検査室における自動化は、診断精度をさらに高め、人的ミスを最小限に抑え、所要時間を短縮しています。遠隔医療も脚光を浴びており、遠隔地の患者は専門のヘルスケアセンターまで足を運ぶことなく、専門家の診断を受けることができます。このような技術革新が進化し続けることで、幅広いヘルスケア環境において、子宮頸部異形成診断がより利用しやすく、費用対効果が高く、信頼できるものとなっています。

子宮頸部異形成診断の需要増加の要因は？

子宮頸部異形成診断の需要拡大には、いくつかの重要な要因があります。子宮頸がんの予防を目的とした政府の取り組みや公衆衛生キャンペーンの増加により、検診の取り組みが活発化しています。さらに、HPV感染のリスクに対する認識の高まりとワクチンの利用可能性が相まって、より多くの女性が定期的な検診を受けるようになっています。ヘルスケアプロバイダーは高度な診断技術を採用するようになっており、新興諸国では医療インフラの拡大により診断サービスがより利用しやすくなっています。さらに、女性の高齢化とともにHPV関連感染症が増加していることから、早期発見への関心が高まり、子宮頸部異形成診断ソリューションへの需要が高まっています。

子宮頸部異形成診断市場の主な成長促進要因は？

子宮頸部異形成診断市場の成長は、検診プログラムの増加、診断技術の進歩、HPV感染率の上昇など、いくつかの要因によってもたらされます。子宮頸がん検診を推進する公衆衛生の取り組み、例えば、無料または低料金のパップスメアを提供する政府支援プログラムは、検査を受ける女性の数を大幅に増加させています。さらに、AIベースのスクリーニングツールや分子診断法の改良といった技術革新が、より正確で効率的な発見に寄与し、市場の成長を促進しています。さらに、発展途上地域におけるヘルスケアインフラの拡大と、子宮頸がん予防における早期発見の重要性に対する意識の高まりが、市場拡大の大きな要因となっています。

セグメント

エンドユーザー（病院、診断センター、個人婦人科医院、研究・学術機関、外来手術センター）、タイプ（診断検査、診断機器）

調査対象企業の例

  • Abbott Molecular, Inc.
  • Becton, Dickinson & Company
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • QIAGEN GmbH
  • Quest Diagnostics, Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールで市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP16261

Global Cervical Dysplasia Diagnostics Market to Reach US$897.7 Million by 2030

The global market for Cervical Dysplasia Diagnostics estimated at US$637.8 Million in the year 2024, is expected to reach US$897.7 Million by 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Diagnostic Tests, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$793.8 Million by the end of the analysis period. Growth in the Diagnostic Devices segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$175.7 Million While China is Forecast to Grow at 5.4% CAGR

The Cervical Dysplasia Diagnostics market in the U.S. is estimated at US$175.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$139.3 Million by the year 2030 trailing a CAGR of 5.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.4% and 4.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Global Cervical Dysplasia Diagnostics Market - Key Trends & Drivers Summarized

Why Is Cervical Dysplasia Gaining More Attention in Healthcare?

Cervical dysplasia is a precancerous condition where abnormal cell growth occurs on the surface of the cervix, primarily due to the human papillomavirus (HPV). Early detection of cervical dysplasia is crucial in preventing the progression to cervical cancer, making diagnostics essential in women's healthcare. As awareness of cervical cancer prevention increases, so too does the importance of diagnostics for identifying and managing cervical dysplasia. With screening programs becoming more widespread and healthcare systems emphasizing preventive measures, there has been a marked rise in the use of Pap smears, HPV testing, and colposcopies. Early diagnosis and intervention can lead to better outcomes, reducing the overall burden of cervical cancer globally, particularly in regions where healthcare access is improving.

How Are Technological Innovations Impacting Cervical Dysplasia Diagnostics?

Technological advancements are reshaping the landscape of cervical dysplasia diagnostics. Modern screening techniques, such as liquid-based cytology and molecular testing for HPV, have enhanced the accuracy of diagnostic procedures, enabling earlier and more precise detection of abnormal cells. Digital colposcopy, AI-driven diagnostic tools, and automation in pathology laboratories are further enhancing diagnostic precision, minimizing human error, and reducing turnaround times. Telemedicine has also gained prominence, allowing patients in remote areas to receive expert diagnoses without needing to travel to specialized healthcare centers. As these innovations continue to evolve, they are making cervical dysplasia diagnostics more accessible, cost-effective, and reliable across a wide range of healthcare settings.

Which Factors Are Leading to Increased Demand for Cervical Dysplasia Diagnostics?

Several key factors are driving the growing demand for cervical dysplasia diagnostics. Increased government initiatives and public health campaigns aimed at preventing cervical cancer have boosted screening efforts. Furthermore, growing awareness of the risks of HPV infection, combined with the availability of vaccines, has encouraged more women to undergo regular screenings. Healthcare providers are increasingly adopting advanced diagnostic techniques, and the expansion of healthcare infrastructure in developing countries has made diagnostic services more available. Additionally, the rise in the number of HPV-related infections, along with an aging female population, has heightened the focus on early detection, leading to greater demand for cervical dysplasia diagnostic solutions.

What Are The Key Growth Drivers of The Cervical Dysplasia Diagnostics Market?

The growth in the cervical dysplasia diagnostics market is driven by several factors, including increased screening programs, advancements in diagnostic technology, and rising HPV infection rates. Public health initiatives promoting cervical cancer screening, such as government-backed programs offering free or low-cost Pap smears, have substantially increased the number of women being tested. Furthermore, innovations like AI-based screening tools and improved molecular diagnostics have contributed to more accurate and efficient detection, driving market growth. Additionally, the expanding healthcare infrastructure in developing regions, coupled with growing awareness about the importance of early detection in preventing cervical cancer, has been a significant driver of market expansion.

SCOPE OF STUDY:

The report analyzes the Cervical Dysplasia Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Hospitals, Diagnostic Centers, Private Gynecologists Offices, Research & Academic Institutes, Ambulatory Surgical Centers); Type (Diagnostic Tests, Diagnostic Devices)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 46 Featured) -

  • Abbott Molecular, Inc.
  • Becton, Dickinson & Company
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • QIAGEN GmbH
  • Quest Diagnostics, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Tariff Impact on Global Supply Chain Patterns
    • Cervical Dysplasia Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of HPV Infections Driving Demand
    • Rising Awareness of Cervical Cancer Screening Programs
    • Advancements in Molecular Diagnostics for Early Detection
    • Growing Adoption of Liquid-Based Cytology for Screening
    • Technological Innovations in HPV DNA Testing
    • Increased Focus on Preventive Healthcare in Developed Markets
    • Integration of AI and Machine Learning in Diagnostic Tools
    • Demand for Point-of-Care Diagnostics in Low-Resource Settings
    • Government Initiatives Promoting Regular Cervical Screening
    • Growing Use of Biomarkers in Cervical Dysplasia Detection
    • Expansion of Diagnostic Services in Emerging Economies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cervical Dysplasia Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cervical Dysplasia Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Cervical Dysplasia Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Diagnostic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Diagnostic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Diagnostic Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Private Gynecologists' Offices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Private Gynecologists' Offices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Private Gynecologists' Offices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Research & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Research & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Research & Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Ambulatory Surgical Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cervical Dysplasia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Cervical Dysplasia Diagnostics by Type - Percentage Breakdown of Value Sales for Diagnostic Tests and Diagnostic Devices for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Cervical Dysplasia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Cervical Dysplasia Diagnostics by Type - Percentage Breakdown of Value Sales for Diagnostic Tests and Diagnostic Devices for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Cervical Dysplasia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • JAPAN
    • Cervical Dysplasia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Cervical Dysplasia Diagnostics by Type - Percentage Breakdown of Value Sales for Diagnostic Tests and Diagnostic Devices for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Cervical Dysplasia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • CHINA
    • Cervical Dysplasia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Cervical Dysplasia Diagnostics by Type - Percentage Breakdown of Value Sales for Diagnostic Tests and Diagnostic Devices for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Cervical Dysplasia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • EUROPE
    • Cervical Dysplasia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Cervical Dysplasia Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Cervical Dysplasia Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Cervical Dysplasia Diagnostics by Type - Percentage Breakdown of Value Sales for Diagnostic Tests and Diagnostic Devices for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Cervical Dysplasia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • FRANCE
    • Cervical Dysplasia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Cervical Dysplasia Diagnostics by Type - Percentage Breakdown of Value Sales for Diagnostic Tests and Diagnostic Devices for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Cervical Dysplasia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • GERMANY
    • Cervical Dysplasia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Cervical Dysplasia Diagnostics by Type - Percentage Breakdown of Value Sales for Diagnostic Tests and Diagnostic Devices for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Cervical Dysplasia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Cervical Dysplasia Diagnostics by Type - Percentage Breakdown of Value Sales for Diagnostic Tests and Diagnostic Devices for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Cervical Dysplasia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Cervical Dysplasia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Cervical Dysplasia Diagnostics by Type - Percentage Breakdown of Value Sales for Diagnostic Tests and Diagnostic Devices for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Cervical Dysplasia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Rest of Europe 15-Year Perspective for Cervical Dysplasia Diagnostics by Type - Percentage Breakdown of Value Sales for Diagnostic Tests and Diagnostic Devices for the Years 2015, 2025 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Europe 15-Year Perspective for Cervical Dysplasia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Cervical Dysplasia Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Asia-Pacific 15-Year Perspective for Cervical Dysplasia Diagnostics by Type - Percentage Breakdown of Value Sales for Diagnostic Tests and Diagnostic Devices for the Years 2015, 2025 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Asia-Pacific 15-Year Perspective for Cervical Dysplasia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Cervical Dysplasia Diagnostics by Type - Diagnostic Tests and Diagnostic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of World 15-Year Perspective for Cervical Dysplasia Diagnostics by Type - Percentage Breakdown of Value Sales for Diagnostic Tests and Diagnostic Devices for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Cervical Dysplasia Diagnostics by End-Use - Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of World 15-Year Perspective for Cervical Dysplasia Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Private Gynecologists' Offices, Research & Academic Institutes and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030

IV. COMPETITION